Company: MDXG
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001376339-25-000048
Chunk: 75

Company: MIMEDX GROUP, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 75
---
 industry and market conditions. Since the Plan was adopted, we have sought to provide equity compensation to our employees who we believe are important to our organization in furthering our business strategy. In addition, we have made multiple leadership appointments and promotions to advance our strategy. We made equity grants from the Plan in connection with each of these new hires and promotions. We believe these new hires and promotions are key to the development and strengthening of the management team with the experience and talent necessary to further implement our strategy.

Shareholder Value Transfer Analysis . When evaluating the appropriate number of shares to increase the share reserve under the Plan, we reviewed the shareholder value transfer of the proposed increase, calculated as the value of available shares and plan awards as a percentage of our market capitalization, and determined that the approval of 7,950,000 new shares under the Plan was reasonable.

Expected Duration . We expect that the shares available for future awards, including the additional shares if this proposal is approved by our shareholders, will be sufficient for currently-anticipated awards under the Plan for approximately the next three years. Expectations regarding future share usage could be impacted by a number of factors such as hiring and promotion activity at the executive level; the rate at which shares are returned to the Plan reserve upon awards’ expiration, forfeiture or cash settlement; the future performance of our stock price which could impact the number of shares being issued under awards; consequences of acquiring other companies; final settlement obligations if PSU performance criteria are exceeded, and other factors. While we believe that the assumptions we used are reasonable, future share usage may differ from current expectations.

For the foregoing reasons, the Board of Directors recommends that our shareholders approve the Amendment.

#### General Plan Information
The Plan is intended to permit the grant of stock options (both incentive stock options (“ ISOs ”) and non-qualified stock options (“ NQSOs ” (collectively “ Options ”)), stock appreciation rights (“ SARs ”), restricted stock awards (“ Restricted Stock Awards ”), performance stock awards (“ Performance Stock Awards ”), restricted stock units (“ RSUs ”), performance stock units (“ PSUs ”), incentive awards (“ Incentive Awards ”), other stock-based awards (“ Stock-Based Awards ”) and dividend equivalents (“ Dividend Equivalents ”) (collectively “ Awards ”). “ Full Value Award ” means an Award other than an Option, SAR or Stock-Based Award in the nature of purchase rights. All Awards granted under the Plan will be governed by separate written or electronic agreements between MiMedx and the participants. The separate